193 related articles for article (PubMed ID: 31297836)
1. Pathogen reduction with amotosalen/UVA reduces platelet refractoriness in a dog platelet transfusion model.
Slichter SJ; Bailey SL; Gettinger I; Pellham E; Christoffel T; Castro G; Green JM; Stassinopoulos A
Vox Sang; 2019 Aug; 114(6):595-604. PubMed ID: 31297836
[TBL] [Abstract][Full Text] [Related]
2. Leukofiltration plus pathogen reduction prevents alloimmune platelet refractoriness in a dog transfusion model.
Slichter SJ; Pellham E; Bailey SL; Christoffel T; Gettinger I; Gaur L; Latchman Y; Nelson K; Bolgiano D
Blood; 2017 Aug; 130(8):1052-1061. PubMed ID: 28705838
[TBL] [Abstract][Full Text] [Related]
3. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet B irradiation in the prevention of alloimmunization in a dog platelet transfusion model.
Slichter SJ; Abrams K; Gettinger I; Christoffel T; Gaur L; Latchman Y; Nelson K; Pellham E; Bailey SL; Bolgiano D
Transfusion; 2016 Jun; 56(6):1340-7. PubMed ID: 27184061
[TBL] [Abstract][Full Text] [Related]
5. Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review.
Cid J
Vox Sang; 2017 Oct; 112(7):607-613. PubMed ID: 28833219
[TBL] [Abstract][Full Text] [Related]
6. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59.
BioDrugs; 2003; 17(1):66-8. PubMed ID: 12534321
[TBL] [Abstract][Full Text] [Related]
7. Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation--a LC-ESI-MS/MS-based proteomics approach.
Thiele T; Sablewski A; Iuga C; Bakchoul T; Bente A; Görg S; Völker U; Greinacher A; Steil L
Blood Transfus; 2012 May; 10 Suppl 2(Suppl 2):s63-70. PubMed ID: 22890270
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen-reduction technology.
Girard YA; Santa Maria F; Lanteri MC
Transfusion; 2020 Mar; 60(3):622-627. PubMed ID: 31957887
[TBL] [Abstract][Full Text] [Related]
9. Further studies to evaluate methods of leucoreduction to prevent alloimmune platelet refractoriness and induce tolerance in a dog platelet transfusion model.
Slichter SJ; Abrams K; Bailey SL; Pellham E; Gettinger I; Christoffel T; Gaur L; Latchman Y; Nelson K; Bolgiano D
Vox Sang; 2016 Jul; 111(1):62-70. PubMed ID: 27007858
[TBL] [Abstract][Full Text] [Related]
10. Patient outcomes and amotosalen/UVA-treated platelet utilization in massively transfused patients.
Nussbaumer W; Amato M; Schennach H; Astl M; Chen CY; Lin JS; Corash L; Benjamin RJ
Vox Sang; 2017 Apr; 112(3):249-256. PubMed ID: 28198023
[TBL] [Abstract][Full Text] [Related]
11. Prevention of platelet alloimmunization in dogs with systemic cyclosporine and by UV-irradiation or cyclosporine-loading of donor platelets.
Slichter SJ; Deeg HJ; Kennedy MS
Blood; 1987 Feb; 69(2):414-8. PubMed ID: 3801661
[TBL] [Abstract][Full Text] [Related]
12. Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates.
Hashem AM; Hassan AM; Tolah AM; Alsaadi MA; Abunada Q; Damanhouri GA; El-Kafrawy SA; Picard-Maureau M; Azhar EI; Hindawi SI
Transfus Med; 2019 Dec; 29(6):434-441. PubMed ID: 31696565
[TBL] [Abstract][Full Text] [Related]
13. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.
Castro G; Merkel PA; Giclas HE; Gibula A; Andersen GE; Corash LM; Lin JS; Green J; Knight V; Stassinopoulos A
Transfusion; 2018 Jun; 58(6):1506-1515. PubMed ID: 29607502
[TBL] [Abstract][Full Text] [Related]
14. The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.
Kaiser-Guignard J; Canellini G; Lion N; Abonnenc M; Osselaer JC; Tissot JD
Blood Rev; 2014 Nov; 28(6):235-41. PubMed ID: 25192602
[TBL] [Abstract][Full Text] [Related]
15. Pathogen inactivation with amotosalen plus UVA illumination minimally impacts microRNA expression in platelets during storage under standard blood banking conditions.
Arnason NA; Johannson F; Landrö R; Hardarsson B; Irsch J; Gudmundsson S; Rolfsson O; Sigurjonsson OE
Transfusion; 2019 Dec; 59(12):3727-3735. PubMed ID: 31674051
[TBL] [Abstract][Full Text] [Related]
16. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
17. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K
Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
[TBL] [Abstract][Full Text] [Related]
18. Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets.
Muench MO; Heitman JW; Inglis H; Fomin ME; Marschner S; Goodrich RP; Norris PJ; Jackman RP
Transfusion; 2016 Jun; 56(6):1419-29. PubMed ID: 27028210
[TBL] [Abstract][Full Text] [Related]
19. Canine platelet alloimmunization: the role of donor selection.
Slichter SJ; O'Donnell MR; Weiden PL; Storb R; Schroeder ML
Br J Haematol; 1986 Aug; 63(4):713-27. PubMed ID: 3730294
[TBL] [Abstract][Full Text] [Related]
20. A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment.
Knutson F; Osselaer J; Pierelli L; Lozano M; Cid J; Tardivel R; Garraud O; Hervig T; Domanovic D; Cukjati M; Gudmundson S; Hjalmarsdottir IB; Castrillo A; Gonzalez R; Brihante D; Santos M; Schlenke P; Elliott A; Lin JS; Tappe D; Stassinopoulos A; Green J; Corash L
Vox Sang; 2015 Nov; 109(4):343-52. PubMed ID: 25981525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
